Ouro Fino Saúde Animal Participações S.A.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Ouro Fino Saúde Animal Participações S.A. - overview
Established
1987
Location
Cravinhos, -, Brazil
Primary Industry
Pharmaceuticals
About
Ouro Fino Saúde Animal Participações S. A. is a Brazilian company dedicated to the development and distribution of veterinary pharmaceuticals and health products that enhance the well-being and productivity of animals. Founded in 1987, Ouro Fino Saúde Animal specializes in veterinary pharmaceuticals.
The company, headquartered in Cravinhos, Brazil, has undergone significant growth, culminating in its most recent funding round, LP Direct, PIPE, and Trade Sale in October 2014, where it raised BRL 344. 6 million. The CEO is Kleber Gomes and Luis Grégio, who have guided the company's operations in the competitive veterinary health market. Ouro Fino Saúde Animal offers a diverse range of veterinary products, including vaccines, antiparasitics, antibiotics, and nutritional supplements aimed at improving the health of livestock, companion animals, and poultry.
Their product line addresses health issues like infectious diseases and nutritional deficiencies, serving veterinarians, farmers, and pet owners predominantly in Brazil and Latin America. The company emphasizes research and development, collaborating with industry partners to innovate and expand its offerings. In the most recent fiscal year 2023, Ouro Fino Saúde Animal reported a revenue of BRL 189,043,438. 80 and an EBITDA of BRL 23,488,113.
30. Their revenue model relies on direct sales to veterinary clinics, agricultural cooperatives, and producers, bolstered by both one-time purchases and ongoing partnerships. Ouro Fino Saúde Animal plans to introduce new products aimed at specific health challenges in the veterinary field, with anticipated launches aligned with customer needs. The company is targeting expansion into new Latin American markets by 2025, leveraging insights gained from its extensive domestic operations.
The funds raised during the October 2014 IPO are expected to support these initiatives, enhancing product development and market outreach.
Current Investors
Opportunity Gestora, Brazilian Development Bank
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.ourofinosaudeanimal.com
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
Ouro Fino Saúde Animal Participações S.A. - timeline of key events
Ouro Fino Saúde Animal Participações S.A. - financials
| Fiscal Year Ended | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 384,021,000 | 432,241,000 | 534,045,000 | 456,587,000 | 505,281,000 | 589,215,000 | 619,585,000 | 730,108,000 | - | - | - |
| % Revenue Growth (YoY) | - | 12.6% | 23.6% | (14.5%) | 10.7% | 16.6% | 5.2% | 17.8% | - | - | - |
| EBITDA (USD) | 79,139,000 | 95,639,000 | 118,034,000 | 30,777,000 | 91,210,000 | 123,506,000 | 96,423,000 | 128,513,000 | - | - | - |
| Operating Income (USD) | 66,654,000 | 79,015,000 | 97,902,000 | 8,850,000 | 66,351,000 | 97,974,000 | 71,796,000 | 102,116,000 | - | - | - |
| Operating Margin | 17.4% | 18.3% | 18.3% | 1.9% | 13.1% | 16.6% | 11.6% | 14.0% | - | - | - |
| % EBITDA Margin | 20.6% | 22.1% | 22.1% | 6.7% | 18.1% | 21.0% | 15.6% | 17.6% | - | - | - |
| NET Income (USD) | 42,005,000 | 51,303,000 | 69,207,000 | (5,351,000) | 37,901,000 | 68,867,000 | 46,278,000 | 89,713,000 | - | - | - |
| % Net Margin | 10.9% | 11.9% | 13.0% | (1.2%) | 7.5% | 11.7% | 7.5% | 12.3% | - | - | - |
Ouro Fino Saúde Animal Participações S.A. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Acquisition | Completed | Ouro Fino Saúde Animal Participações S.A. | - | ||||||||
| LP Direct, PIPE, Trade Sale | Completed | Ouro Fino Saúde Animal Participações S.A. | - | ||||||||
| PIPE, Secondary Buyout | Completed | Ouro Fino Saúde Animal Participações S.A. | - | ||||||||
| IPO | Completed | Ouro Fino Saúde Animal Participações S.A. | - | ||||||||
| PIPE | Completed | Ouro Fino Saúde Animal Participações S.A. | - |
Displaying 1 - 5 of 6
Ouro Fino Saúde Animal Participações S.A. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.